SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Hirsch Fred R)
 

Sökning: WFRF:(Hirsch Fred R) > (2022) > Expression patterns...

  • Megyesfalvi, ZsoltMedical University of Vienna,National Institute of Oncology, Budapest,National Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)

Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer : an international multicenter study

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • 2022-05-25
  • Wiley,2022
  • 13 s.

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:faf38cfe-d716-4c27-a886-02947864930a
  • https://lup.lub.lu.se/record/faf38cfe-d716-4c27-a886-02947864930aURI
  • https://doi.org/10.1002/path.5922DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • The tissue distribution and prognostic relevance of subtype-specific proteins (ASCL1, NEUROD1, POU2F3, YAP1) present an evolving area of research in small-cell lung cancer (SCLC). The expression of subtype-specific transcription factors and P53 and RB1 proteins were measured by immunohistochemistry (IHC) in 386 surgically resected SCLC samples. Correlations between subtype-specific proteins and in vitro efficacy of various therapeutic agents were investigated by proteomics and cell viability assays in 26 human SCLC cell lines. Besides SCLC-A (ASCL1-dominant), SCLC-AN (combined ASCL1/NEUROD1), SCLC-N (NEUROD1-dominant), and SCLC-P (POU2F3-dominant), IHC and cluster analyses identified a quadruple-negative SCLC subtype (SCLC-QN). No unique YAP1-subtype was found. The highest overall survival rates were associated with non-neuroendocrine subtypes (SCLC-P and SCLC-QN) and the lowest with neuroendocrine subtypes (SCLC-A, SCLC-N, SCLC-AN). In univariate analyses, high ASCL1 expression was associated with poor prognosis and high POU2F3 expression with good prognosis. Notably, high ASCL1 expression influenced survival outcomes independently of other variables in a multivariate model. High POU2F3 and YAP1 protein abundances correlated with sensitivity and resistance to standard-of-care chemotherapeutics, respectively. Specific correlation patterns were also found between the efficacy of targeted agents and subtype-specific protein abundances. In conclusion, we investigated the clinicopathological relevance of SCLC molecular subtypes in a large cohort of surgically resected specimens. Differential IHC expression of ASCL1, NEUROD1, and POU2F3 defines SCLC subtypes. No YAP1-subtype can be distinguished by IHC. High POU2F3 expression is associated with improved survival in a univariate analysis, whereas elevated ASCL1 expression is an independent negative prognosticator. Proteomic and cell viability assays of human SCLC cell lines revealed distinct vulnerability profiles defined by transcription regulators.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Barany, NandorNational Korányi Institute for Tuberculosis and Pulmonology, Hungary,Semmelweis University,Medical University of Vienna (författare)
  • Lantos, AndrasNational Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)
  • Valko, ZsuzsannaMedical University of Vienna,National Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)
  • Pipek, OrsolyaEötvös Loránd University (författare)
  • Lang, ChristianMedical University of Vienna (författare)
  • Schwendenwein, AnnaMedical University of Vienna (författare)
  • Oberndorfer, FelicitasMedical University of Vienna (författare)
  • Paku, SandorSemmelweis University (författare)
  • Ferencz, BenceNational Institute of Oncology, Budapest,National Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)
  • Dezso, KatalinSemmelweis University (författare)
  • Fillinger, JanosNational Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)
  • Lohinai, ZoltanNational Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)
  • Moldvay, JuditNational Korányi Institute for Tuberculosis and Pulmonology, Hungary,Hungarian Academy of Sciences (författare)
  • Galffy, Gabriella (författare)
  • Szeitz, BeataSemmelweis University (författare)
  • Rezeli, MelindaLund University,Lunds universitet,Avdelningen för Biomedicinsk teknik,Institutionen för biomedicinsk teknik,Institutioner vid LTH,Lunds Tekniska Högskola,Masspektrometri,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,BioMS,Forskargrupper vid Lunds universitet,Clinical Protein Science and Imaging,Biomarkörer och Epi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Department of Biomedical Engineering,Departments at LTH,Faculty of Engineering, LTH,Mass Spectrometry,Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups,Biomarkers and epidemiology,Section I,Department of Clinical Sciences, Lund(Swepub:lu)elma-mrl (författare)
  • Rivard, ChristopherUniversity of Colorado (författare)
  • Hirsch, Fred R.University of Colorado (författare)
  • Brcic, LukaMedical University of Graz (författare)
  • Popper, HelmutMedical University of Graz (författare)
  • Kern, IzidorUniversity Clinic Golnik (författare)
  • Kovacevic, MileUniversity Clinic Golnik (författare)
  • Skarda, JozefPalacký University,University Hospital Ostrava (författare)
  • Mittak, MarcelUniversity Hospital Ostrava (författare)
  • Marko-Varga, GyorgyLund University,Lunds universitet,Avdelningen för Biomedicinsk teknik,Institutionen för biomedicinsk teknik,Institutioner vid LTH,Lunds Tekniska Högskola,Clinical Protein Science and Imaging,Forskargrupper vid Lunds universitet,Department of Biomedical Engineering,Departments at LTH,Faculty of Engineering, LTH,Lund University Research Groups(Swepub:lu)akem-gmv (författare)
  • Bogos, KrisztinaNational Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)
  • Renyi-Vamos, FerencNational Institute of Oncology, Budapest,National Korányi Institute for Tuberculosis and Pulmonology, Hungary (författare)
  • Hoda, Mir AlirezaMedical University of Vienna (författare)
  • Klikovits, ThomasMedical University of Vienna (författare)
  • Hoetzenecker, KonradMedical University of Vienna (författare)
  • Schelch, KarinMedical University of Vienna (författare)
  • Laszlo, ViktoriaNational Korányi Institute for Tuberculosis and Pulmonology, Hungary,National Institute of Oncology, Budapest,Medical University of Vienna (författare)
  • Dome, BalazsNational Institute of Oncology, Budapest,Medical University of Vienna,National Korányi Institute for Tuberculosis and Pulmonology, Hungary(Swepub:lu)ba1464do (författare)
  • Medical University of ViennaNational Institute of Oncology, Budapest (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of Pathology: Wiley257:5, s. 674-6860022-34171096-9896

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy